SUMMERSET FPO NZX (SNZ)
SNZ $5.35
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 5.35
- Change
- ▲ 0.14 (2.69)
- Bid / Ask
- 5.11 - 5.35
- Volume
- 11
- Turnover
- 59
- Open
- 5.21
- Day Range
- 5.21 - 5.35
- VWAP
- 5.34
- Prev Close
- 5.21
- Last Trade
- 13/11 12:32pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Healthcare
- Shares Issued
- 244,915,544
- NTA/Share
- 13.72
- Last Dividend
- 0.03
- Dividend Ex Date
- 9 SEP 2026
- Dividend Pay Date
- 23 SEP 2026
Current (NZD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 360.86
- EBITDA
- 193.60
- Profit
- 259.72
- Earnings Per Share (EPS)
- 1.08
- Dividend Per Share (DPS)
- 0.21
- Yield %
- 2.22
- Market Cap
- 1,307.39
- Price to Earnings Ratio (P/E)
- 5.24
Estimates (NZD) · FY2026
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 4,681.17
- EBITDA
- 1,222.84
- Profit
- —
- Earnings Per Share (EPS)
- 3.18
- Dividend Per Share (DPS)
- —
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Moderate
- Uncertainty
- High
Morningstar Quantitative Rating as of 13 NOV 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 5.01 Fair value 6.17 One-star price 7.60
Morningstar Quantitative Rating as of 13 NOV 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 6.17
- Price / Fair Value
- 0.87
- Valuation
- Undervalued
- Uncertainty
- High
Morningstar Quantitative Rating as of 13 NOV 2026. The slider runs from the five-star price (5.01) to the one-star price (7.60).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): AUD/NZD |
| Exchange Rate: 0.8153 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 5.35 |
| Price - 12 month high | 12.09 |
| Price - 12 month low | 4.99 |
| Pricing date | 12 NOV 2026 |
| Volume - avg. trading volume for the last ten days | 0.00 |
| Market capitalization | 1,310.30 |
| 12 Month High price date | 7 JAN 2026 |
| 12 Month Low price date | 9 NOV 2026 |
| Volume - avg. trading volume for the last 3 months | 0.00 |
| Price - 1 Day % Change | 2.69% |
| Price - 13 week price percent change | -22.46% |
| Price - 26 week price percent change | -15.08% |
| Price - 5 Day % Change | 3.28% |
| Price - 52 week price percent change | -49.05% |
| Price - YTD price percent change | -49.14% |
| Price % Change Month To Date | -2.73% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 1.079 |
| EPS excluding extraordinary items - trailing 12 month | 1.255 |
| EPS Normalized - most recent fiscal year | 0.972 |
| Revenue/share - most recent fiscal year | 1.499 |
| Revenue/share - trailing 12 month | 1.604 |
| Book value per share - most recent fiscal year | 13.731 |
| Book value per share - most recent half-year | 14.421 |
| Book value (tangible) per share - most recent fiscal year | 13.719 |
| Book value (tangible) per share - most recent half-year | 14.413 |
| Cash per share - most recent fiscal year | 0.025 |
| Cash per share - most recent half-year | 0.058 |
| Cash Flow per share - most recent fiscal year | 2.159 |
| Cash Flow per share - trailing 12 month | 2.290 |
| Dividend per share - most recent fiscal year | — |
| Dividends per share - trailing 12 month | 0.119 |
| EBITD per share - trailing 12 month | 1.104 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 1.081 |
| EPS Basic excluding extraordinary items - trailing 12 month | 1.257 |
| EPS including extraordinary items - most recent fiscal year | 1.081 |
| EPS including extraordinary items - trailing 12 month | 1.257 |
| Free Cash Flow per share - trailing 12 month | 1.771 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 4.94 |
| P/E Normalized, most recent fiscal year | 4.90 |
| Price to sales - most recent fiscal year | 3.86 |
| Price to Tangible Book - most fiscal year | 0.45 |
| Price to Free Cash Flow per Share - most recent fiscal year | 3.50 |
| Price to Cash Flow per share - trailing 12 month | 2.71 |
| Price to Book - most recent fiscal year | 0.45 |
| P/E excluding extraordinary items high, trailing 12 months | 9.09 |
| P/E excluding extraordinary items low, trailing 12 months | 4.64 |
| Net Debt, LFI | 5,712.92 |
| Net Debt, LFY | 1,965.74 |
| Dividend Yield - 5 Year Average | 1.80% |
| Dividend Yield - indicated annual dividend divided by closing price | 2.37% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 2.22% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 299.28 |
| LT debt/equity - most recent fiscal year | 59.44% |
| Payout ratio - most recent fiscal year | — |
| Total debt/total equity - most recent fiscal year | 59.44% |
| LT debt/equity - most recent half-year | 163.11% |
| Total debt/total equity - most recent half-year | 163.11% |
| Free Cash Flow - trailing 12 month | 428.64 |
| Payout ratio - trailing 12 month | — |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 360.86 |
| Revenue - trailing 12 month | 388.36 |
| EBITD - most recent fiscal year | 193.60 |
| EBITD - trailing 12 month | 267.16 |
| Earnings before taxes - most recent fiscal year | 241.12 |
| Earnings before taxes - trailing 12 month | 310.43 |
| Net Income available to common - most recent fiscal year | 259.72 |
| Net Income available to common - trailing 12 months | 303.98 |
| Earnings before taxes Normalized - most recent fiscal year | -23.33 |
| Net Income Available to Common, Normalized - most recent fiscal year | 234.15 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 1.26 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 71.97% |
| Net Profit Margin % - trailing 12 month | 78.27% |
| Operating margin - 1st historical fiscal year | 1.64% |
| Operating margin - trailing 12 month | 3.97% |
| Pretax margin - trailing 12 month | 79.93% |
| Pretax margin - 1st historical fiscal year | 66.82% |
| Operating Margin - 5 year average | 3.90% |
| Pretax Margin - 5 year average | 143.12% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 114.91% |
| Free Operating Cash Flow/Revenue, TTM | 110.37% |
| Net Profit Margin - 5 year average | 144.51% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 3.00% |
| Return on average assets - trailing 12 month | 3.29% |
| Return on average equity - most recent fiscal year | 8.23% |
| Return on average equity - trailing 12 month | 9.11% |
| Return on average assets - 5 year average | 5.86% |
| Return on average equity - 5 year average | 15.72% |
| Net Income/employee - most recent fiscal year | — |
| Revenue/employee - most recent fiscal year | — |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 15.92% |
| EPS growth rate, 5 year | 1.28% |
| Growth rate% - dividend, 3 year | 8.24% |
| Revenue/share (5 yr growth) | 14.66% |
| Growth rate% - Revenue, 3 year | 15.05% |
| Growth rate% - EPS, 3 year | -2.50% |
| Book value per share growth rate, 5 year | 18.14% |
| Capital Spending growth rate, 5 year | 53.14% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | -2.30% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (NZD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | |||||||
| Estimate breakdown |
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (NZD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
| DATE | TIME | HEADING | PAGES |
| Price sensitive |
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Summerset Group Holdings Ltd develops, owns, and operates integrated retirement villages. The company receives a majority of its revenue from the New Zealand Ministry of Health, which subsidizes fees for eligible aged-care residents. Its revenue is mainly derived from care fees and village services income. Summerset provides a range of care for its residents, including in-home care and 24-hour medical care centers. In addition to its independent-living villas and apartments,Summerset offers supported-living residences, which include assistance with daily activities like shopping and housekeeping.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
